B. subtilis Recombinant, Oxalate oxidase (OxOx)from Biovision |
|
| P1091-100 | each: 810.00 EUR |
|
B. subtilis Recombinant, Oxalate oxidase (OxOx)from Biovision |
|
| P1091-20 | each: 222.00 EUR |
|
(S)-(+)-3-(Benzyloxyxarbonyl)-5-ox-4-oxazolidineacetic Acidfrom Toronto Research Chemicals |
|
| B286285 | 2.5g: 385.00 EUR |
|
|
Description: 23632-66-8 |
|
9-Oxo-xanthene-2-carboxylic Acid Methyl Esterfrom Toronto Research Chemicals |
|
| O867230 | 2.5g: 3000.00 EUR |
|
|
Description: 42946-50-9 |
|
9-Oxo-xanthene-2-carboxylic Acid Methyl Esterfrom Toronto Research Chemicals |
|
| TRC-O867230-2.5G | 2.5 g: Ask for price |
|
9-Oxo-xanthene-2-carboxylic Acid Methyl Ester-D3from Toronto Research Chemicals |
|
| O867232 | 25mg: 3000.00 EUR |
|
9-Oxo-xanthene-2-carboxylic Acid Methyl Ester-D3from Toronto Research Chemicals |
|
| TRC-O867232-25MG | 25 mg: Ask for price |
|
OX02983from MedKoo Biosciences |
|
| 525869 | 1.0mg: 70.00 EUR |
|
OX01914from MedChemExpress |
|
| HY-150078 | Get quote: Ask for price |
|
|
Description: OX01914 is a water-solube and permeable utrophin modulator (upregulates utrophin protein levels), with an EC50 of 20.5 μM. OX01914 can be used in study of duchenne muscular dystrophy (DMD)[1]. |
|
OX04528from MedChemExpress |
|
| HY-161106 | Get quote: Ask for price |
|
|
Description: OX04528 (compound 68) is a potent, G-protein biased, and orally active GPR84 agonist. OX04528 no cytotoxicity. OX04528 inhibits cAMP production with an EC50 value of 0.00598 nM[1]. |
|
OX04529from MedChemExpress |
|
| HY-161107 | Get quote: Ask for price |
|
|
Description: OX04529 (compound 69) is a potent, selective and orally active agonist of GPR84. OX04529 inhibits FSK-induced cAMP production with an EC50 of 0.0185 nM. OX04529 displayed excellent potency, high G-protein signaling bias[1]. |
|
OX01914from TargetMol Chemicals |
|
| T60594-10mg | 10mg: Ask for price |
|
|
Description: OX01914 |
|
OX01914from TargetMol Chemicals |
|
| T60594-1g | 1g: Ask for price |
|
|
Description: OX01914 |
|
OX01914from TargetMol Chemicals |
|
| T60594-1mg | 1mg: Ask for price |
|
|
Description: OX01914 |
|
OX01914from TargetMol Chemicals |
|
| T60594-50mg | 50mg: Ask for price |
|
|
Description: OX01914 |
|
OX01914from TargetMol Chemicals |
|
| T60594-5mg | 5mg: Ask for price |
|
|
Description: OX01914 |
|
CD134, Mouse (OX40)(OX-86), 1mg/mLfrom Biotium |
|
| BNUM2004-50 | 1uL: 396.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), 0.2mg/mLfrom Biotium |
|
| BNUB2004-100 | 1uL: 225.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), 0.2mg/mLfrom Biotium |
|
| BNUB2004-500 | 1uL: 485.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
APC Anti-Mouse CD134 (OX40) (OX-86)from MyBiosource |
|
| MBS4165252-01mg | 0.1mg: 510.00 EUR |
|
APC Anti-Mouse CD134 (OX40) (OX-86)from MyBiosource |
|
| MBS4165252-5x01mg | 5x0.1mg: 2040.00 EUR |
|
PerCP-Cy5.5 Anti-Mouse CD134 (OX40) (OX-86)from MyBiosource |
|
| MBS4165603-01mg | 0.1mg: 625.00 EUR |
|
PerCP-Cy5.5 Anti-Mouse CD134 (OX40) (OX-86)from MyBiosource |
|
| MBS4165603-5x01mg | 5x0.1mg: 2555.00 EUR |
|
CD134, Mouse (OX40)(OX-86), CF568 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC682004-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF568 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC682004-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF594 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC942004-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF594 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC942004-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF647 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC472004-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF647 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC472004-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF488A conjugate, 0.1mg/mLfrom Biotium |
|
| BNC882004-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF488A conjugate, 0.1mg/mLfrom Biotium |
|
| BNC882004-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), Biotin conjugate, 0.1mg/mLfrom Biotium |
|
| BNCB2004-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), Biotin conjugate, 0.1mg/mLfrom Biotium |
|
| BNCB2004-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF640R conjugate, 0.1mg/mLfrom Biotium |
|
| BNC402004-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF640R conjugate, 0.1mg/mLfrom Biotium |
|
| BNC402004-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF405S conjugate, 0.1mg/mLfrom Biotium |
|
| BNC042004-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
CD134, Mouse (OX40)(OX-86), CF405S conjugate, 0.1mg/mLfrom Biotium |
|
| BNC042004-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), 1mg/mLfrom Biotium |
|
| BNUM3108-50 | 1uL: 396.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), 0.2mg/mLfrom Biotium |
|
| BNUB3108-100 | 1uL: 225.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), 0.2mg/mLfrom Biotium |
|
| BNUB3108-500 | 1uL: 485.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
Anti-CD200R [OX108]from MyBiosource |
|
| MBS488073-02mg | 0.2mg: 520.00 EUR |
|
Anti-CD200R [OX108]from MyBiosource |
|
| MBS488073-5x02mg | 5x0.2mg: 2160.00 EUR |
|
Anti-CD200R [OX108]from MyBiosource |
|
| MBS488074-02mg | 0.2mg: 520.00 EUR |
|
Anti-CD200R [OX108]from MyBiosource |
|
| MBS488074-5x02mg | 5x0.2mg: 2160.00 EUR |
|
OX40 Ligand/TNFSF4/OX40Lfrom EnoGene |
|
| E21-M74 | 10ug: 225.00 EUR |
|
|
Description: Recombinant Mouse OX40 Ligand is produced by our Mammalian expression system and the target gene encoding Ser51-Leu198 is expressed with a 8His tag at the N-terminus. |
|
PE Anti-Human CD200 (OX-104)from MyBiosource |
|
| MBS4165439-100Tests | 100Tests: 445.00 EUR |
|
PE Anti-Human CD200 (OX-104)from MyBiosource |
|
| MBS4165439-5x100Tests | 5x100Tests: 1745.00 EUR |
|
OX40 Ligand/TNFSF4/OX40Lfrom MyBiosource |
|
| MBS8533022-001mg | 0.01mg: 305.00 EUR |
|
OX40 Ligand/TNFSF4/OX40Lfrom MyBiosource |
|
| MBS8533022-5x001mg | 5x0.01mg: 1220.00 EUR |
|
Human OX40 Ligand,OX40L ELISA KITfrom Jotbody |
|
| JOT-EK3845Hu | 96 wells: Ask for price |
|
|
Description: Human |
|
Human OX40 Ligand,OX40L ELISA KITfrom Jiaxing Korain Biotech Ltd (BT Labs) |
|
| E3845Hu-1096T | 10*96T: 4122.00 EUR |
|
Human OX40 Ligand,OX40L ELISA KITfrom Jiaxing Korain Biotech Ltd (BT Labs) |
|
| E3845Hu-48wells | 48 wells: 300.00 EUR |
|
Human OX40 Ligand,OX40L ELISA KITfrom Jiaxing Korain Biotech Ltd (BT Labs) |
|
| E3845Hu-596T | 5*96T: 2061.00 EUR |
|
Human OX40 Ligand,OX40L ELISA KITfrom Jiaxing Korain Biotech Ltd (BT Labs) |
|
| E3845Hu-96wells | 96 wells: 458.00 EUR |
|
Human OX40 Ligand (OX40L) ELISA Kitfrom MyBiosource |
|
| MBS167187-10x96StripWells | 10x96-Strip-Wells: 3460.00 EUR |
|
Human OX40 Ligand (OX40L) ELISA Kitfrom MyBiosource |
|
| MBS167187-48StripWells | 48-Strip-Wells: 285.00 EUR |
|
Human OX40 Ligand (OX40L) ELISA Kitfrom MyBiosource |
|
| MBS167187-5x96StripWells | 5x96-Strip-Wells: 1750.00 EUR |
|
Human OX40 Ligand (OX40L) ELISA Kitfrom MyBiosource |
|
| MBS167187-96StripWells | 96-Strip-Wells: 425.00 EUR |
|
Human OX40 Ligand (OX40L) ELISA Kitfrom MyBiosource |
|
| MBS3800183-10x96StripWells | 10x96-Strip-Wells: 6725.00 EUR |
|
Human OX40 Ligand (OX40L) ELISA Kitfrom MyBiosource |
|
| MBS3800183-48StripWells | 48-Strip-Wells: 550.00 EUR |
|
Human OX40 Ligand (OX40L) ELISA Kitfrom MyBiosource |
|
| MBS3800183-5x96StripWells | 5x96-Strip-Wells: 3420.00 EUR |
|
Human OX40 Ligand (OX40L) ELISA Kitfrom MyBiosource |
|
| MBS3800183-96StripWells | 96-Strip-Wells: 765.00 EUR |
|
Anti-SIRP-beta & gamma [OX117]from MyBiosource |
|
| MBS488315-02mg | 0.2mg: 520.00 EUR |
|
Anti-SIRP-beta & gamma [OX117]from MyBiosource |
|
| MBS488315-5x02mg | 5x0.2mg: 2160.00 EUR |
|
Anti-SIRP-beta & gamma [OX117]from MyBiosource |
|
| MBS488316-02mg | 0.2mg: 520.00 EUR |
|
Anti-SIRP-beta & gamma [OX117]from MyBiosource |
|
| MBS488316-5x02mg | 5x0.2mg: 2160.00 EUR |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF568 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC683108-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF568 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC683108-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF594 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC943108-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF594 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC943108-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF647 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC473108-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF647 conjugate, 0.1mg/mLfrom Biotium |
|
| BNC473108-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
Mouse Anti-Human CD200 mAb (PE) [OX-104]from EnoGene |
|
| E2782307 | 100tests: 485.00 EUR |
|
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF488A conjugate, 0.1mg/mLfrom Biotium |
|
| BNC883108-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF488A conjugate, 0.1mg/mLfrom Biotium |
|
| BNC883108-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), Biotin conjugate, 0.1mg/mLfrom Biotium |
|
| BNCB3108-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), Biotin conjugate, 0.1mg/mLfrom Biotium |
|
| BNCB3108-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF640R conjugate, 0.1mg/mLfrom Biotium |
|
| BNC403108-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF640R conjugate, 0.1mg/mLfrom Biotium |
|
| BNC403108-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF405S conjugate, 0.1mg/mLfrom Biotium |
|
| BNC043108-100 | 1uL: 192.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF405S conjugate, 0.1mg/mLfrom Biotium |
|
| BNC043108-500 | 1uL: 532.00 EUR |
|
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|
Mouse Anti-Human CD200 mAb (APC) [OX-104]from EnoGene |
|
| E2782308 | 100tests: 485.00 EUR |
|
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|
Mouse Anti-Human CD200 mAb (PE/Cy7) [OX-104]from EnoGene |
|
| E2782852 | 100tests: 485.00 EUR |
|
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|
Anti-Rat CD2/LFA-2/OX-34 Antibody (OX-34)from MyBiosource |
|
| MBS1569909-01mg | 0.1mg: 405.00 EUR |
|
Anti-Rat CD2/LFA-2/OX-34 Antibody (OX-34)from MyBiosource |
|
| MBS1569909-5x01mg | 5x0.1mg: 1520.00 EUR |
|
PE Anti-human CD200 Antibody *OX-104*from AAT Bioquest |
|
| 120001L0 | 25 tests: 183.00 EUR |
|
|
Description: OX-104 is an anti-human monoclonal antibody that forms an immune complex with the CD200 antigen. |
|
PE Anti-human CD200 Antibody *OX-104*from AAT Bioquest |
|
| 120001L0-25tests | 25 tests: 179.00 EUR |
|
|
Description: OX-104 is an anti-human monoclonal antibody that forms an immune complex with the CD200 antigen. |
|
PE Anti-human CD200 Antibody *OX-104*from AAT Bioquest |
|
| 120001L1 | 100 tests: 516.00 EUR |
|
|
Description: OX-104 is an anti-human monoclonal antibody that forms an immune complex with the CD200 antigen. |
|
Gynecologic cytology, Lung, Thyroid, Liver & Pancreas